NASDAQ:MDRX - Allscripts Healthcare Solutions Stock Price, Price Target & More Sign in or create an account to add this stock to your watchlist. Get Started $11.65 -0.33 (-2.75 %) (As of 07/22/2018 02:52 AM ET)Previous Close$11.65Today's Range$11.62 - $12.0152-Week Range$10.78 - $16.13Volume1.67 million shsAverage Volume1.28 million shsMarket Capitalization$2.13 billionP/E Ratio24.79Dividend YieldN/ABeta1.25 Company ProfileFinancialsAnalyst RatingsEarnings HistoryInsider TradesHeadlinesOptions ChainSEC FilingsSocial MediaChart Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Allscripts Healthcare Solutions, Inc. provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records, connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions. The company's Clinical and Financial Solutions segment provides integrated clinical software applications and financial and information solutions, which primarily include EHR-related, and financial and practice management software solutions, as well as related installation, support and maintenance, outsourcing, private cloud hosting, revenue cycle management, training, and electronic claims administration services. Its Population Health segment offers health management and coordinated care solutions that enable hospitals, health systems, accountable care organizations, and other care facilities to connect, transition, analyze, and coordinate care across the entire care community. The company's Netsmart segment operates in and provides software and technology solutions to the health and human services, and post-acute sectors of health care. The company serves physicians, hospitals, governments, health systems, health plans, life-sciences companies, retail clinics, retail pharmacies, pharmacy benefit managers, insurance companies, and employer wellness clinics, as well as post-acute organizations, such as home health and hospice agencies. Allscripts Healthcare Solutions, Inc. was founded in 1986 and is headquartered in Chicago, Illinois. Receive MDRX News and Ratings via Email Sign-up to receive the latest news and ratings for MDRX and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Computer integrated systems design Sub-IndustryHealth Care Technology SectorMedical SymbolNASDAQ:MDRX CUSIP01988P10 Webwww.allscripts.com Phone312-506-1200 Debt Debt-to-Equity Ratio1.53 Current Ratio1.02 Quick Ratio1.02 Price-To-Earnings Trailing P/E Ratio24.79 Forward P/E Ratio21.18 P/E Growth1.59 Sales & Book Value Annual Sales$1.81 billion Price / Sales1.15 Cash Flow$1.6385 per share Price / Cash7.11 Book Value$6.42 per share Price / Book1.81 Profitability EPS (Most Recent Fiscal Year)$0.47 Net Income$-152,600,000.00 Net Margins-11.34% Return on Equity7.80% Return on Assets2.20% Miscellaneous Employees8,900 Outstanding Shares177,950,000Market Cap$2,131.87 Allscripts Healthcare Solutions (NASDAQ:MDRX) Frequently Asked Questions What is Allscripts Healthcare Solutions' stock symbol? Allscripts Healthcare Solutions trades on the NASDAQ under the ticker symbol "MDRX." How were Allscripts Healthcare Solutions' earnings last quarter? Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) announced its quarterly earnings results on Thursday, May, 3rd. The software maker reported $0.16 EPS for the quarter, missing the consensus estimate of $0.17 by $0.01. The software maker earned $518.60 million during the quarter, compared to analysts' expectations of $527.34 million. Allscripts Healthcare Solutions had a positive return on equity of 7.80% and a negative net margin of 11.34%. The firm's revenue for the quarter was up 24.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.13 EPS. View Allscripts Healthcare Solutions' Earnings History. When is Allscripts Healthcare Solutions' next earnings date? Allscripts Healthcare Solutions is scheduled to release their next quarterly earnings announcement on Thursday, August, 2nd 2018. View Earnings Estimates for Allscripts Healthcare Solutions. What guidance has Allscripts Healthcare Solutions issued on next quarter's earnings? Allscripts Healthcare Solutions updated its FY18 earnings guidance on Thursday, May, 3rd. The company provided EPS guidance of $0.72-0.82 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.77. The company issued revenue guidance of $2.15-2.25 billion, compared to the consensus revenue estimate of $2.19 billion. What price target have analysts set for MDRX? 15 brokerages have issued twelve-month price objectives for Allscripts Healthcare Solutions' stock. Their forecasts range from $12.00 to $19.00. On average, they anticipate Allscripts Healthcare Solutions' share price to reach $16.5093 in the next twelve months. This suggests a possible upside of 41.7% from the stock's current price. View Analyst Ratings for Allscripts Healthcare Solutions. What is the consensus analysts' recommendation for Allscripts Healthcare Solutions? 15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Allscripts Healthcare Solutions in the last year. There are currently 1 sell rating, 1 hold rating and 13 buy ratings for the stock, resulting in a consensus recommendation of "Buy." What are Wall Street analysts saying about Allscripts Healthcare Solutions stock? Here are some recent quotes from research analysts about Allscripts Healthcare Solutions stock: 1. According to Zacks Investment Research, "Falling margins and soaring operating expenses are major concerns for Allscripts at the moment. The company is also exposed to integration risks. Intense competition in the niche space adds to the woes. As a result of all these factors, the company had a dull start to 2018 with lackluster sales performance. On the positive side, strong segmental revenues in the last reported quarter and a solid guidance for 2018 buoy optimism. Year-over-year rise in bookings is also a major positive. The company recently acquired HealthGrid, which will ensure a significant expansion of the company’s FollowMyHealth platform. Solid international ventures and innovation also hold promise. Moreover, Allscripts’ iPro Anesthesia will be implemented by Singapore-based SingHealth. Allscripts has outperformed the industry in a year’s time." (7/3/2018) 2. Cantor Fitzgerald analysts commented, ". We reiterate our Overweight rating on MDRX shares. The stock offers 43% upside potential to our 12-month price target of $18. We continue to believe that Allscripts’ growth outlook has improved after a series of strategic acquisitions. The acquisitions of McKesson’s EIS business and Practice Fusion added a significant amount of recurring revenue. With its 1Q18 release, the company announced the acquisition of privately-held HealthGrid, a provider of patient engagement tools to providers. Finally, at a recent competitor conference, the company indicated it has been pretty active" in stock repurchases in 2Q18, after repurchasing $50 million in 1Q18." (6/8/2018) 3. Maxim Group analysts commented, "1Q18 bookings of $304M, up 6.3% y/y, was below our estimate of $315M, but relatively inline with consensus of $305M." (5/4/2018) Who are some of Allscripts Healthcare Solutions' key competitors? Some companies that are related to Allscripts Healthcare Solutions include CSRA (CSRA), Scientific Games (SGMS), CACI INTERNATIONAL INC Common Stock (CACI), Science Applications International (SAIC), Verint Systems (VRNT), Ebix (EBIX), NetScout Systems (NTCT), Convergys (CVG), Sykes Enterprises (SYKE), Quality Systems (QSII), VASCO Data Security International (VDSI), Onespan (OSPN), Ribbon Communications (RBBN), Unisys (UIS) and KEYW (KEYW). Who are Allscripts Healthcare Solutions' key executives? Allscripts Healthcare Solutions' management team includes the folowing people: Mr. Paul M. Black, CEO & Director (Age 60)Mr. Richard J. Poulton, Pres (Age 53)Mr. Dennis M. Olis, Chief Financial Officer (Age 55)Mr. Brian P. Farley, Exec. VP, Gen. Counsel & Chief Admin. Officer (Age 48)Ms. Lisa Khorey, Exec. VP & Chief Client Delivery Officer (Age 51) Has Allscripts Healthcare Solutions been receiving favorable news coverage? News articles about MDRX stock have trended somewhat positive recently, according to Accern. Accern identifies negative and positive press coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Allscripts Healthcare Solutions earned a news sentiment score of 0.17 on Accern's scale. They also gave news headlines about the software maker an impact score of 46.44 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next few days. Who are Allscripts Healthcare Solutions' major shareholders? Allscripts Healthcare Solutions' stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Fisher Asset Management LLC (2.86%), Dalton Greiner Hartman Maher & Co. (1.78%), Boston Advisors LLC (0.33%), Campbell & CO Investment Adviser LLC (0.04%), Municipal Employees Retirement System of Michigan (0.02%) and Bank of Montreal Can (0.01%). Company insiders that own Allscripts Healthcare Solutions stock include Brian Farley, James Hewitt, Michael Klayko, Paul Black and Richard J Poulton. View Institutional Ownership Trends for Allscripts Healthcare Solutions. Which major investors are selling Allscripts Healthcare Solutions stock? MDRX stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Fisher Asset Management LLC, Municipal Employees Retirement System of Michigan, Boston Advisors LLC, Foundry Partners LLC and Creative Planning. Company insiders that have sold Allscripts Healthcare Solutions company stock in the last year include Brian Farley, James Hewitt, Paul Black and Richard J Poulton. View Insider Buying and Selling for Allscripts Healthcare Solutions. Which major investors are buying Allscripts Healthcare Solutions stock? MDRX stock was bought by a variety of institutional investors in the last quarter, including Dalton Greiner Hartman Maher & Co., Campbell & CO Investment Adviser LLC, Fox Run Management L.L.C. and Whittier Trust Co. of Nevada Inc.. View Insider Buying and Selling for Allscripts Healthcare Solutions. How do I buy shares of Allscripts Healthcare Solutions? Shares of MDRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Allscripts Healthcare Solutions' stock price today? One share of MDRX stock can currently be purchased for approximately $11.65. How big of a company is Allscripts Healthcare Solutions? Allscripts Healthcare Solutions has a market capitalization of $2.13 billion and generates $1.81 billion in revenue each year. The software maker earns $-152,600,000.00 in net income (profit) each year or $0.47 on an earnings per share basis. Allscripts Healthcare Solutions employs 8,900 workers across the globe. How can I contact Allscripts Healthcare Solutions? Allscripts Healthcare Solutions' mailing address is 222 MERCHANDISE MART SUITE 2024, CHICAGO IL, 60654. The software maker can be reached via phone at 312-506-1200 or via email at [email protected] MarketBeat Community Rating for Allscripts Healthcare Solutions (NASDAQ MDRX)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 500 (Vote Outperform)Underperform Votes: 488 (Vote Underperform)Total Votes: 988MarketBeat's community ratings are surveys of what our community members think about Allscripts Healthcare Solutions and other stocks. Vote "Outperform" if you believe MDRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MDRX will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 7/22/2018 by MarketBeat.com StaffFeatured Article: What is the Book Value of a Share?